INTRODUCTION
AFE is an obstetric catastrophe where a woman in labor suddenly collapses. It is postulated that amniotic fluid, fetal cells, hair, or other debris enter the maternal circulation, and causes cardio respiratory collapse. Steiner and Luschbaugh described AFE for the first time in 1941 after they found fetal debris in the pulmonary circulation of women who died during labor at post mortem. 3 They described the condition as peri-partum shock. The entry of amniotic fluid into circulation was first described by Ricardo Meyer in 1926. 4 Data from the National Amniotic Fluid Embolus Registry describes the process of AFE as similar to anaphylaxis than to embolism. The term anaphylactoid syndrome of pregnancy is now given because fetal tissue or amniotic fluid components are not found in all women who present with signs and symptoms similar to AFE. 2, 5, 6 The diagnosis is essentially one of exclusion based on clinical presentation. Other causes of hemodynamic instability should not be neglected. In a critically ill patient, a blood sample obtained by aspiration from pulmonary artery catheter that contains fetal squamous cells is considered suggestive of but not diagnostic of AFE syndrome. 
INCIDENCE
It is difficult to estimate the correct incidence of AFE but it is said to be in the range from 1 in 8000 to 1 in 80000 pregnancies. 1 The registry for AFE was maintained by Clark et al in USA 2 and Tuffnel et al. in UK. 7 The incidence of maternal deaths has drastically reduced in developed countries in the past 30 years due to the advancement in resuscitation methods. Though the mortality has come down, both the maternal and fetal morbidity are still very high. The majority of patients with AFE die within the first hour of onset of symptoms and 85% of those who survive have permanent neurological deficit. If the fetus is alive at the time of 1 embolism, 70% may survive delivery but 50% of those neonates who survive will have neurological damage.
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PATHOPHYSIOLOGY
The pathophysiology of AFE has not been understood well. It is believed that amniotic fluid and fetal cells enter the maternal circulation, and triggers an anaphylactic reaction to the fetal antigens. Fetal material is not always found in the maternal circulation in patients with AFE. All women with amniotic fluid cells in circulation also do not develop features of amniotic fluid embolism Usually during labor or any other invasive procedure during the antenatal period, amniotic fluid and debris, or some yet unidentified substance, enters the maternal circulation. This triggers a massive anaphylactic reaction, and activation of the complement cascade Progression occurs in 2 phases. This was described by Clark.
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Phase I, Pulmonary artery vasospasm with pulmonary hypertension and increased right ventricular pressure causes hypoxia. 11 This hypoxia causes myocardial capillary damage and pulmonary capillary damage, left heart failure, and acute respiratory distress syndrome. Women who survive these events may enter phase II. Phase 1 may last up to 30 minutes.
Phase II: Hemorrhagic phase. Fatal consumptive coagulopathy may be the initial presentation. This is characterized by massive hemorrhage with uterine atony and DIC; there may be left ventricular failure and pulmonary edema as well. 
CLINICAL FEATURE
History
Amniotic Fluid Embolism (AFE) usually occurs during labor.
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The syndrome typically occurs during labor or soon after vaginal or caesarean delivery, or during second-trimester dilation and evacuation procedures. In the United States national registry, 70% of the cases occurred during labor 19% were recorded during caesarean delivery, and 11% occurred after vaginal delivery. 2 All the cases noted during caesarean section had their onset soon after the delivery of the fetus. There is constant relation of AFE to rupture of fetal membranes. Of the women included in the United States National Registry, 78% had ruptured membranes. Placental abruption was confirmed in 13% of women. 13 These findings suggest that certain conditions like artificial rupture of membranes; abruption; hypertonic contractions during induction of labor and dilatation and curettage may permit exposure of fetal tissue to the maternal vasculature and may increase the risk for AFE. 10 Prodromal symptoms in AFE are sudden chills, shivering, sweating, anxiety, and coughing followed by signs of respiratory distress, shock, cardiovascular collapse, and convulsions. 12 Respiratory difficulty, evidenced by cyanosis, tachypnea, and bronchospasm, frequently culminates in fulminant pulmonary edema.
Cyanosis, restlessness, convulsions, coma, reflex tachypnea and cardiovascular collapse is due to hypoxia and results from the decreased arterial oxygen saturation. This is heralded by hypotension, tachycardia, and arrhythmia and may end in cardiac arrest.
Convulsions may be an early manifestation of the central nervous system involvement combined with cerebral ischemia and this may lead to coma and death. If the patient survives this initial episode, bleeding occur The following signs and symptoms are indicative of possible AFE:
1. Hypotension: Blood pressure drops significantly with loss of diastolic measurement.
2. Dyspnea with cough: Labored breathing and tachypnea occur.
3. Cyanosis: As hypoxia/hypoxemia progresses, circum oral and peripheral cyanosis occurs and changes in mucous membranes may also be seen.
4. Pulmonary edema: This is usually identified on chest radiograph.
5. Cardiac arrest.
6. Seizure: Generalized tonic clonic seizures are seen in 50% of patients.
7. Fetal bradycardia: In response to the hypoxic insult, fetal heart rate may drop to less than 110 beats per minute (bpm). If this drop lasts for 10 minutes or more, it is a bradycardia. A rate of 60 bpm or less over 3-5 minutes may indicate a terminal bradycardia. Immediate delivery of the fetus is indicated.
8. Uterine atony: Uterine atony usually results in excessive bleeding after delivery. Failure of the uterus to become firm with bimanual massage is diagnostic.
9. Coagulopathy or severe hemorrhage in the absence of other explanation (DIC occurs in 83% of patients).
10. Altered mental status/confusion/agitation. The Sialyl Tn antigen test was described by Kobayashi and colleagues, who showed that monoclonal antibodies TKH-2, MA54, B72.3, and CC49 react with meconium and amniotic fluid-derived mucin. 16 TKH-2 has the ability to detect the lowest concentration of the antigen.
Sialyl is a mucin-type glycoprotein that originates in fetal and adult intestinal and respiratory tracts. It is a major component in meconium (10% by weight) and is also present in clear amniotic fluid. 16 Using a sensitive anti-mucin antibody TKH-2, the authors found no difference in the serum levels of Sialyl Tn antigen in pregnant patients throughout gestation or in early post-partum period when compared with nonpregnant controls.
In contrast, the antigen concentrations were significantly elevated in patients with AFE. The monoclonal antibody TKAH-2 may eventually prove useful in rapid, noninvasive diagnosis of AFE.
Plasma concentration of zinc coproporphyrin, a characteristic component of meconium, has shown to be greater in patients with suspected AFE. At present, clinical experience with the Sialyl Tn antigen and zinc coproporphyrin is limited and further studies are needed to assess the reliability and utility of these tests DIFFERENTIAL DIAGNOSIS 11 As we have mentioned, amniotic fluid embolism is a diagnosis of exclusion. Hence the knowledge of differential diagnosis is very important. 17 1. Thrombotic pulmonary embolism -This is associated with chest pain. It occurs in the post-partum period and there will be definite evidence of venous thrombosis 18 2. Eclampsia -Convulsions may be common to both. But shock is seen in AFE. Hypertension proteinuria and convulsions are pathognomonic of eclampsia 19 3. Air embolism -Auscultation will reveal water wheel murmur over pericardium. There will be associated chest pain in both 19 4. Acute left heart failure-Seen in patients with previous history of heart disease. There will be associated murmur. ECHO will clinch the diagnosis 5. Drug reaction to anesthetic drugs 6. Cerebrovascular accidents (CVA)-In CVA there will be no cyanosis hypotension or pulmonary edema 7. Aspiration of gastric contents 8. Hemorrhagic shock in an obstetric patient associated with ruptured uterus, uterine inversion, abruptio placenta, and placenta praevia
MANAGEMENT
The key factors in the management of AFE are early recognition, prompt resuscitation, and delivery of fetus. Approach should be multidisciplinary involving anesthetists, obstetricians, hematologists and intensivists.
Treatment is supportive.
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 Administer oxygen to maintain normal saturation. Intubate if necessary.
 Initiate cardiopulmonary resuscitation (CPR) if the patient has cardiac arrest.
 Treat hypotension with crystalloid and blood products. Use pressor agents when necessary.
 Consider pulmonary artery catheterization in patients who are hemodynamically unstable.
 Continuously monitor the fetus and ensure prompt delivery.
 Treat coagulopathy.
 FFP for a prolonged PT  Cryoprecipitate for a fibrinogen level less than 100 mg/dL, It is impossible to predict high risk patients for Amniotic fluid embolism.
Diagnosis is based on a spectrum of clinical signs and symptoms and by exclusion of other causes that produce such symptoms.
Most cases of AFE are associated with high maternal and fetal morbidity and mortality, regardless of the quality of care rendered.
Improved understanding of the pathophysiology of AFE may lead to the development of preventive measures and more effective and specific treatment. Although there are many new developments with respect to the understanding of the disease, amniotic fluid embolism continues to be a catastrophic illness requiring a high index of suspicion, a multidisciplinary approach and rapid resuscitation efforts in order to have a desirable clinical outcome.
We must develop national and international registries and encourage collaboration between research centers. Without a specific method to confirm the diagnosis and registries to collect the data, our understanding of the natural history, etiology and treatment will continue to be hampered.
